Mydriasis

Updated: May 14, 2023

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

phenylephrine hydrochloride and tropicamide ophthalmic

Indicated for diagnostic procedures and short-term pupil dilation:

Spray the cornea of each eye with one measured spray, then wait 5 minutes and repeat. The tropicamide and phenylephrine HCl in each metered spray is 0.008 mL (0.08 mg and 0.2 mg, respectively)

phentolamine ophthalmic (FDA Approval Pending)

FDA Approval Pending for reversal of pharmacologically induced mydriasis produced by adrenergic agonist or parasympatholytic agents.

phentolamine ophthalmic

Put 1 or 2 drops in each dilated eye after completion of the ophthalmic examination
If 2 drops putted, then the second drop should be administered 5 minutes after the first drop

phentolamine ophthalmic

for 3 to 11 years old:
Put 1 drop in each dilated eye after completion of the ophthalmic examination
for >12 years old:
Put 1 or 2 drops in each dilated eye after completion of the ophthalmic examination
If 2 drops putted, then the second drop should be administered 5 minutes after the first drop

Future Trends